I am not aware of any recent cost effectiveness studies comparing one triptan against the others. But triptans on the whole are probably worth the cost, if the cost of hospital attendances, need for other medications and , loss of productive working hours for parents/carers are taken into account. However this might not apply in the same way in all health systems
Excelent point, Biju. Of course, it depends on the different health system situations.
For example, in Argentina the costs triptans/ergotamine is 5:1 and efectiveness is similar.
On the other hand, ergotamine is considered risky in adults (paediatricians are not sure but we only use in older than 12 years).
This demands a search for evidence in literature. Any opinion or file will be welcome.
Interesting. That seems to be a huge difference in costs triptans vs ergots. In the UK ergots are hardly prescribed since triptans became available. Regarding the efficacy of triptans particularly the nasal spray, there is enough strong evidence already. The most common complaint is about the bad aftertaste it leaves after spraying !!. There is a nice 2 part review in J Headache Pain. 2011 Feb;12(1) ( PMID21359874 & PMID21170567 )